Preferred Label : Leuprolide Mesylate;

NCIt definition : The mesylate salt form of leuprolide, a synthetic nonapeptide analogue of gonadotropin-releasing hormone (GnRH), with potential antineoplastic activity. Upon administration, leuprolide binds to and activates the gonadotropin-releasing hormone receptor (GnRHR). The continuous stimulation of GnRHR by leuprolide results in both the desensitization of pituitary GnRHR and the inhibition of pituitary secretion of the gonadotropins follicle stimulating hormone (FSH) and luteinizing hormone (LH). In males, this results in a significant decline in testosterone production to castration levels and may inhibit androgen receptor-positive tumor progression.;

UNII : 8E3C3C493W;

CAS number : 944347-41-5;

Drug name : Camcevi;

NCI Metathesaurus CUI : CL1799374;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3637601/fr/camcevi-leuproreline-cancer-de-la-prostate
2025
false
false
false
France
Leuprolide Mesylate
Leuprolide Mesylate Injectable Suspension
treatment outcome
insurance, health, reimbursement
antineoplastic agents, hormonal
Hormone-dependent prostate cancer
neoplasms, hormone-dependent
advanced hormone-dependent prostate cancer
High Risk Prostate Carcinoma
Localized Prostate Carcinoma
Delayed-Action preparations
injections, subcutaneous
leuprorelin
evaluation of the transparency committee
leuprolide
prostatic neoplasms

---
Nous contacter.
09/09/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.